According to the report published by Visiongain, the Metagenomics Market was valued at approximately USD xx billion in 2019. Metagenomics is a study of microbes that involves the complex microbial communities in their natural living environment. The research explores the molecular structure of the body as a whole, and each of its microbes. It is an important concept which is seen to be interdependent and seen as a family instead of as separate entities by the microbes and the host. During the last five-10 years, Metagenomics has demonstrated a new field of research in which the vast majority of organisms in most environments around the world are explained by non-cultured microbes. The study of metagenomics allows users to discover the tools for the creation of new biotechnological DNA, enzymes and chemical compounds. In addition, metagenomic libraries are an essential tool for the development of new enzyme activities that allow genetic monitoring for all potential biotechnological applications. This study explores the roots of microbial ecology and biotechnology and its modern use.
The global market for metagenomics is driven largely by increasing requirements to implement high quality DNA sequencing processes that differ from those conventionally used. In addition, the use of modern techniques in genomics without requiring isolation and laboratory cultivation of single species covers the bulk of metagenomics processes. And as many researchers perform comprehensive research in this area, a steady presence is expected on the global metagenomics sector.
A highly consolidated and narrow selling landscape depicts the global metagenomics market. This is mainly because of the presence of a few players on the market who are responsible for most of the processes. However, the competition can witness significant growth and thus attract large revenues, as the numbers of players are forecast to increase.
Metagenomics Has Become A Powerful Weapon To Examine The Microbial Populations
At this early stage of metagenomics, the main focus of work is non-eukaryotic bacteria, although the analysis is expected to cover all biological fields in a timely fashion. Metagenomics has become a powerful weapon to examine the microbial populations independent of their potential for laboratory culture using traditional isolation and has also been able to describe their microbial heterogeneity in the ecosystem since many can not yet been cultured. Metagenomics has become a strong weapon for science. This refers to the extraction of DNA from a community to bring together all of the organisms ‘ genomes in the community. Metagenomics is also described as environmental and community genomics which involves genomic microorganisms analysis through direct extraction and cloning of DNA from a microorganism assembly in the majority of earth environments, such as water or soil. Generic genomes are isolated from the environment, fragmented, and subsequently cloned into an organism using their replicable plasmid. Organisms are then cultivated for metagenomic libraries and analyzes are then performed on the basis of DNA.
The Approach To The Large Demand For New Enzymes And Biocatalysts Has Proven To Be Strong In Metagenomics
Metagenomics has proved to be a fast growing weapons in the microbial world and changed the way microbiologists face many challenges. Metagenomics, the genomic analysis of a microorganism population, has proven to be a powerful central element of the methods aimed at gaining access to the physiology and genetics of uncropped organizationsHigher 1% of the microorganisms in the natural environment can be grown in the laboratory. It was calculated. Incrodible microbes with chemical, biological and functional activities are becoming increasingly known to contain a large amount of natural products for potential use in various industrial and biomedical applications. For the development of new genes, proteins, organic products, bioactive compounds and bioprocesses that have a significant effect in industrial and biotechnological applications, Metagenomics provides an infinite tool.
The approach to the large demand for new enzymes and biocatalysts has proven to be strong in metagenomics. Metagenomics have been used to generate cellulases, lipases, xylanases, amylases, proteases and many other industrial enzymes. Some of the key enzymes released from genetically untapped resources are as follows.
Metagenomics and Medicine
In the latter half of the 20th century, many antibiotics and many other drugs were isolated d from bacteria and show significant change throughout human health. The separation from the microorganism of natural products by the traditional method contributes however to the rediscovery of established antibiotics (97%). New approach is therefore needed to discover new drugs. Metagenomics can be one of the best origins of new antibiotics.
Regional Analysis
In 2019, North America dominated the sales market. The presence of many leading biotechnology companies, most of which are focused on the development of metagenomic workflows, can be attributed to this. In May 2015, for example, in the Illumina BaseSpace Apps for use with NGS platforms, CosmosID launched its GENIUS Metagenomics application.
Due to the constant advances to improve bioinformatics technology and genomics in countries like India and China, Asia-Pacific is expected to experience the most rapid economic growth in the projected timeframe. Significant variations in climate and environment across Asian countries is expected to positively influence the adoption of these methods in future.
Competition in the global Market
The business segment Agilent CrossLab provides consumer and service supplies. The organization offers a range of chemical and service delivery services that can link the whole laboratory. The diagnosis and genomics section is covered in five business areas that provide solutions including instruments, reagents, consumer products and software that enable customers in the fields of cellular and molecular research to question samples. Illumina offers also a variety of CLIA-certified, CAP-accredited laboratory sequencing, genotyping and NIPT services. Illumina offers various service including Human Whole-Genome Sequencing (WGS) Services, Microarray Services, Certified Service Provider Program (CSPro), Instrument Services, Training and Consulting, and Other Services.
Why you should buy Metagenomics Market Forecast 2020-2030: Forecasts and Analysis by Technology (Sequencing, Bioinformatics), by Products (Instruments, Software, Consumables), by Application (Infectious Disease Diagnosis, Environmental Remediation, Gut Microbe Characterization, Biotechnology, Biofuel, Agriculture) and Geography, with Profiles of Leading Companies.
What is the future of the Metagenomics Market? Visiongain’s comprehensive analysis contains highly quantitative content delivering solid conclusions benefiting your analysis and illustrates new opportunities and potential revenue streams helping you to remain competitive. This definitive report will benefit your decision making and help to direct your future business strategy.
We guarantee in this 171 page report you will receive the following key information –
• View Metagenomics Market forecasts and analysis from 2020-2030 to keep you ahead of your competitors and ensure you exploit key business opportunities
– The report provides detailed sales projections of the market, the competitors, and the commercial drivers and restraints allowing you to more effectively compete in the market. In addition to market forecasts from 2020-2030, our new study shows current market data, original critical analysis, and revealing insight into commercial developments
– Metagenomics Market revenue forecast
– Metagenomics Market connections forecast
• Examine 122 tables, charts, and graphs.
– Let our analysts present you with a thorough assessment of the current and future Metagenomics Market market prospects.
– This analysis will achieve quicker, easier understanding. Also you will gain from our analyst’s industry expertise allowing you to demonstrate your authority on the Metagenomics Market sector
• Discover sales predictions for the key end use submarkets from 2020-2030
– What are the dynamics of the Metagenomics Market industry? Which submarkets will generate the most revenue? Use our forecasts and expert insight to grow your business and give you more industry influence. Find where you can gain and how your organisation can succeed. Avoid falling behind. Stay informed about the potential for each of these Metagenomics Market submarkets with individual forecasts and analysis from 2020-2030.
– Technology submarket forecast 2020-2030
– Product submarket forecast 2020-2030
– Application submarket forecast 2020-2030
• Learn about the market prospects for the leading Metagenomics Market market segments 2020-2030
– How will various value chain members perform over the forecast period? Discover where the highest revenue potential lies from 2020-2030, learning about how Metagenomics Market revenue trickles down through the various market segments. These forecasts will also reveal the competitive landscape. You will see what is happening, explaining the challenges, trends, competitors, and market opportunities. Our report reveals forecasts for the 3 leading segmentations as follows.
– Technology Revenue Forecast 2020-2030
Sequencing Market Forecast, 2020-2030
Bioinformatics Market Forecast, 2020-2030
Other Technology Market Forecast, 2020-2030
– Product Revenue Forecast 2020-2030
Instruments Market Forecast, 2020-2030
Software Market Forecast, 2020-2030
Consumables Market Forecast, 2020-2030
Other Product Market Forecast, 2020-2030
– Application Revenue Forecast 2020-2030
Infectious disease diagnosis Market Forecast, 2020-2030
Gut microbe characterization Market Forecast, 2020-2030
Agriculture Market Forecast, 2020-2030
Environmental remediation Market Forecast, 2020-2030
Biofuel Market Forecast, 2020-2030
Biotechnology Market Forecast, 2020-2030
Other Application Market Forecast, 2020-2030
• Understand the prospects for the 4 regional and the leading 12 national Metagenomics Market markets – where will the highest revenues and opportunities occur?
– Learn about the market potential for Metagenomics Market companies in the developed and developing countries, from 2019 onwards. You will see where and how opportunities exist with revealing individual market forecasts and analysis from 2020-2030 for 12 leading national markets by revenue, as well as segmented regional forecasts
• Explore the factors affecting Metagenomics Market product developers, and everyone within the value chain. Learn about the forces influencing market dynamics.
– Discover what the present and future outlook for business will be. Learn about the following business critical issues
– Research and development (R&D) strategy
– Technological issues and constraints.
– Competition from new product types
– Increasing specialisation by leading players
– Increasing industry consolidation.
– Advances in product quality
– Analysis of barriers to entry
• Identify who the leading companies are in the Metagenomics Market industry
– Our report reveals the technologies and companies which hold the greatest potential. In particular, exploring and analyzing the activities of these companies: See where the expected gains will be. View visiongain’s assessment of the prospects for established competitors, rising companies, and new market entrants. Our work explains that potential, helping you stay ahead. Gain a thorough understanding of the competitive landscape with profiles of 10 leading Metagenomics Market companies examining their positioning, capabilities, product portfolios, R&D activity, services, focus, strategies, M&A activity, and future outlook.
Leading Companies in the Global Metagenomics Market
– PerkinElmer, Inc.,
– Swift Biosciences, Inc
– Bio-Rad Laboratories
– Merck KGaA
– Promega Corporation
– Luminex Corporation
– BGI Group
– DNAstar, Inc.
– Eurofins Scientific
– GENEWIZ
– Illumina, Inc.
Discover Information found nowhere else in this independent assessment of the Metagenomics Market
The Metagenomics Market Forecast 2020-2030: Forecasts and Analysis By Technology, By Product, By Application and Geography, with Profiles of Leading Companies, with Profiles of Leading Companies report provides impartial Metagenomics Market sector analysis. With the independent business intelligence found only in our work, you will discover where the prospects are for profit. In particular, our new research provides you with key strategic advantages: Our informed forecasts, independent and objective analysis, exclusive interviews and revealing company profiles will provide you with that necessary edge, allowing you to gain ground over your competitors.
With this report you are less likely to fall behind in knowledge or miss crucial business opportunities. You will save time and receive recognition for your market insight. See how you this report could benefit and enhance your research, analysis, company presentations and ultimately your individual business decisions and your company’s prospects.
What makes this report unique?
Visiongain’s research methodology involves an exclusive blend of primary and secondary sources providing informed analysis. This methodology allows insight into the key drivers and restraints behind market dynamics and competitive developments. The report therefore presents an ideal balance of qualitative analysis combined with extensive quantitative data including global, submarket and regional markets forecasts from 2020-2030.
How the Metagenomics Market Forecast 2020-2030: Forecasts and Analysis By Technology, By Product, By Application and Geography, with Profiles of Leading Companies report can benefit you
Visiongain’s report is for anyone requiring analysis of the Metagenomics Market. You will discover market forecasts, technological trends, predictions and expert opinion providing you with independent analysis derived from our extensive primary and secondary research. Only by purchasing this report will you receive this critical business intelligence revealing where revenue growth is likely and where the lucrative potential market prospects are. Don’t miss this key opportunity to gain a competitive advantage.
Avoid falling behind your competitors, overlooking critical business opportunities or losing industry influence. In our new report you will discover forecasts from 2020-2030 at the global, submarket, and national level. The report also assesses technologies, competitive forces and expected product pipeline developments. Read on to discover the prospects for the Metagenomics Market sector and find out what its future market prospects are.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Metagenomics Market Forecast 2020-2030: Forecasts and Analysis by Technology (Sequencing, Bioinformatics), by Products (Instruments, Software, Consumables), by Application (Infectious Disease Diagnosis, Environmental Remediation, Gut Microbe Characterization, Biotechnology, Biofuel, Agriculture) and Geography, with Profiles of Leading Companies. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Global Metagenomics Market Definition
1.2 Global Metagenomics Market Overview
1.3 Global Metagenomics Market Segmentation
1.4 Research Scope of Metagenomics in the Industry
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Key Questions Answered by This Analytical Report
1.8 Methodology
1.8.1 Secondary Research
1.8.2 Market Evaluation & Forecasting Methodology
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain
2. Introduction to Metagenomics Systems Market
2.1 Market Definition
2.2 Industry Outlook
2.3 Value Chain Analysis
2.4 Industry Structure
2.5 Current Status & Trends
2.6 Demand & Supply Analysis
2.7 Trade Analysis
2.8 Price Trend Analysis
3. Global Metagenomics Market Analysis
3.1 PEST Analysis of the Metagenomics Market
3.2 Expert Opinion
3.2.1 Primary Correspondents
3.3 Market Outlook
3.4 Drivers & Restraints
3.5 Dominant Region/Country
3.6 Market Scenario
3.7 Overall Growth Rate, Globally
3.8 SWOT Analysis of the Metagenomics Market
3.8.1 Strengths
3.8.2 Weaknesses
3.8.3 Opportunities
3.8.4 Threats
3.9 Porter’s Five Forces Analysis
3.9.1 Competitive Rivalry
3.9.2 Supplier Power
3.9.3 Buyer Power
3.9.4 Threat of Substitute
3..9.5 Threat of New Entrant
4. Metagenomics: Global Market Analysis by Segments
4.1 Global Metagenomics Market Forecast, by Technology 2020-2030
4.1.1 Technology Overview
4.1.2 Sequencing Market Forecast, 2020-2030
4.1.3 Bioinformatics Market Forecast, 2020-2030
4.1.4 Other Technology Market Forecast, 2020-2030
4.2 Global Metagenomics Market Forecast, by Product 2020-2030
4.2.1 Product Overview
4.2.2 Instruments Market Forecast, 2020-2030
4.2.3 Software Market Forecast, 2020-2030
4.2.4 Consumables Market Forecast, 2020-2030
4.2.5 Other Product Market Forecast, 2020-2030
4.3 Global Metagenomics Market Forecast, by Application 2020-2030
4.3.1 Application Overview
4.3.2 Infectious disease diagnosis Market Forecast, 2020-2030
4.3.3 Gut microbe characterization Market Forecast, 2020-2030
4.3.4 Agriculture Market Forecast, 2020-2030
4.3.5 Environmental remediation Market Forecast, 2020-2030
4.3.6 Biofuel Market Forecast, 2020-2030
4.3.7Biotechnology Market Forecast, 2020-2030
4.3.8 Other Application Market Forecast, 2020-2030
5. Leading Regions in Metagenomics Market 2020-2030
5.1 Regional Overview
5.1.1 North America
5.1.2 Europe
5.1.3 Asia Pacific
5.1.4 LAMEA
5.1.5 Leading Countries/ Regions
5.2 North America Metagenomics Market Forecast, 2020-2030
5.2.1 North America Metagenomics Submarket, By Technology Forecast 2020-2030
5.2.2 North America Metagenomics Submarket, By Product Forecast 2020-2030
5.2.3 North America Metagenomics Submarket, By Application Forecast 2020-2030
5.2.4 North America Metagenomics Submarket, By Country Forecast 2020-2030
5.2.4.1 U.S. Metagenomics Market, Forecast 2020-2030
5.2.4.2 Canada Metagenomics Market, Forecast 2020-2030
5.2.4.3 Mexico Metagenomics Market, Forecast 2020-2030
5.3 Europe Metagenomics Market Forecast, 2020-2030
5.3.1 Europe Metagenomics Submarket, By Technology Forecast 2020-2030
5.3.2 Europe Metagenomics Submarket, By Product Forecast 2020-2030
5.3.3 Europe Metagenomics Submarket, By Application Forecast 2020-2030
5.3.4 Europe Metagenomics Submarket, By Country Forecast 2020-2030
5.3.4.1 U.K. Metagenomics Market, Forecast 2020-2030
5.3.4.2 Germany Metagenomics Market, Forecast 2020-2030
5.3.4.3 France Metagenomics Market, Forecast 2020-2030
5.3.4.4 Italy Metagenomics Market, Forecast 2020-2030
5.3.4.5 Spain Metagenomics Market, Forecast 2020-2030
5.3.4.6 The Netherlands Metagenomics Market, Forecast 2020-2030
5.3.4.7 Rest of Europe Metagenomics Market, Forecast 2020-2030
5.4 Asia-Pacific Metagenomics Market Forecast, 2020-2030
5.4.1 Asia-Pacific Metagenomics Submarket, By Technology Forecast 2020-2030
5.4.2 Asia-Pacific Metagenomics Submarket, By Product Forecast 2020-2030
5.4.3 Asia-Pacific Metagenomics Submarket, By Application Forecast 2020-2030
5.4.4 Asia-Pacific Metagenomics Submarket, By Country Forecast 2020-2030
5.4.4.1 China Metagenomics Market, Forecast 2020-2030
5.4.4.2 India Metagenomics Market, Forecast 2020-2030
5.4.4.3 Japan Metagenomics Market, Forecast 2020-2030
5.4.4.4 Korea Metagenomics Market, Forecast 2020-2030
5.4.4.5 Indonesia Metagenomics Market, Forecast 2020-2030
5.4.4.6 Australia Metagenomics Market, Forecast 2020-2030
5.4.4.7 Rest of Asia-Pacific Metagenomics Market, Forecast 2020-2030
5.5 Rest of World Metagenomics Market Forecast, 2020-2030
5.5.1 Rest of World Metagenomics Submarket, By Technology Forecast 2020-2030
5.5.2 Rest of World Metagenomics Submarket, By Product Forecast 2020-2030
5.5.3 Rest of World Metagenomics Submarket, By Application Forecast 2020-2030
6. Leading Companies in The Metagenomics Market
6.1 PerkinElmer, Inc.,
6.1.1 PerkinElmer, Inc., Overview
6.1.2 Analysis of PerkinElmer, Inc., Products and Services
6.1.3 PerkinElmer, Inc., Primary Market Competitors 2019
6.1.4 PerkinElmer, Inc., Key Developments
6.2 Swift Biosciences, Inc
6.2.1 Swift Biosciences, Inc Company Overview
6.2.2 Analysis of Swift Biosciences, Inc Products and Services
6.2.3 Swift Biosciences, Inc Primary Market Competitors 2019
6.2.4 Swift Biosciences, Inc Key Developments
6.3 Bio-Rad Laboratories
6.3.1 Bio-Rad Laboratories Company Overview
6.3.2 Analysis of Bio-Rad Laboratories Products and Services
6.3.3 Bio-Rad Laboratories Primary Market Competitors 2019
6.3.4 Bio-Rad Laboratories Key Developments
6.4 Merck KGaA
6.4.1 Merck KGaA Company Overview
6.4.2 Analysis of Merck KGaA Products and Services
6.4.3 Merck KGaA Primary Market Competitors 2019
6.4.4 Merck KGaA Key Developments
6.5 Promega Corporation
6.5.1 Promega Corporation Company Overview
6.5.2 Analysis of Promega Corporation Products and Services
6.5.3 Promega Corporation Primary Market Competitors 2019
6.5.4 Promega Corporation Key Developments
6.6 Luminex Corporation
6.6.1 Luminex Corporation Company Overview
6.6.2 Analysis of Luminex Corporation Products and Services
6.6.3 Luminex Corporation Primary Market Competitors 2019
6.6.4 Luminex Corporation Key Developments
6.7 BGI Group
6.6.1 BGI Group Company Overview
6.6.2 Analysis of BGI Group Products and Services
6.6.3 BGI Group Primary Market Competitors 2019
6.6.4 BGI Group Key Developments
6.8 DNAstar, Inc.
6.8.1 DNAstar, Inc. Company Overview
6.8.2 Analysis of DNAstar, Inc. Products and Services
6.8.3 DNAstar, Inc. Primary Market Competitors 2019
6.8.4 DNAstar, Inc. Key Developments
6.9 Eurofins Scientific
6.9.1 Eurofins Scientific Company Overview
6.9.2 Analysis of Eurofins Scientific Products and Services
6.9.3 Eurofins Scientific Primary Market Competitors 2019
6.9.4 Eurofins Scientific Key Developments
6.10 GENEWIZ
6.10.1 GENEWIZ Company Overview
6.10.2 Analysis of GENEWIZ Products and Services
6.10.3 GENEWIZ Primary Market Competitors 2019
6.10.4 GENEWIZ Key Developments
7. Conclusions and Recommendations
7.1. Key Research Findings
7.2. Conclusion by Geography
7.3. Conclusion by Solution Type
7.4. Strategic Recommendations
8. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain Report Evaluation Form
List of Figures
Figure 1.1 Global Metagenomics Market Segmentation
Figure 2.1 Metagenomics Value Chain Analysis
Figure 3.1 Metagenomics Supply-Demand Analysis
Figure 4.1 Global Metagenomics Forecast 2020-2030 ($billion, AGR %)
Figure 4.2 Global Metagenomics Market Forecast 2020-2030
Figure 4.3 Global Metagenomics Submarket Forecast by 2020-2030 ($ billion)
Figure 4.4 Global Metagenomics Market By Technology Share Forecast 2019, 2025, 2030 (% Share)
Figure 4.19 Global Metagenomics by Submarket By Technology Forecast 2020-2030 ($ million)
Figure 4.20 Global Metagenomics Market, by Share Forecast 2019, 2025, 2030 (% Share)
Figure 4.21 Metagenomics Market, By Product Forecast 2020-2030 ($billion, AGR%)
Figure 4.23 Metagenomics Market, By Application System Forecast 2020-2030 ($billion, AGR%)
Figure 4.25 Metagenomics Market, By Technology Forecast 2020-2030 ($billion, AGR%)
Figure 4.27 Metagenomics Market, By Product Forecast 2020-2030 ($billion, AGR%)
Figure 5.1 Regional/Country Metagenomics Market, by 2020-2030
Figure 5.3 Leading Country/Regional Metagenomics Market Share, by 2020
Figure 5.4 Leading Country/Regional Metagenomics Market Share, by 2025
Figure 5.5 Leading Country/Regional Metagenomics Market Share, by 2030
Figure 5.6 Europe Metagenomics Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.7 Europe Metagenomics Market, by Forecast 2020-2030
Figure 5.8 Europe Metagenomics Submarket, By Technology Forecast 2020-2030
Figure 5.9 Europe Metagenomics Submarket , By Product Forecast 2020-2030
Figure 5.10 Europe Metagenomics Submarket , By Country Forecast 2020-2030
Figure 5.11 Europe Metagenomics Submarket , By Application 2020-2030 ($billion, AGR%)
Figure 5.10 North America Metagenomics Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.11 North America Metagenomics Market, by Forecast 2020-2030
Figure 5.12 North America Metagenomics Submarket, By Technology Forecast 2020-2030
Figure 5.13 North America Metagenomics Submarket , By Product Forecast 2020-2030
Figure 5.14 North America Metagenomics Submarket , By Application Forecast 2020-2030
Figure 5.13 North America Metagenomics Submarket , By Country Forecast 2020-2030
Figure 5.14 Asia-Pacific Metagenomics Market Forecast 2020-2030 ($billion , AGR%)
Figure 5.15 Asia-Pacific Metagenomics Market, by Forecast 2020-2030
Figure 5.16 Asia-Pacific Metagenomics Submarket, By Technology Forecast 2020-2030
Figure 5.17 Asia-Pacific Metagenomics Submarket , By Country Forecast 2020-2030
Figure 5.17 Asia-Pacific Metagenomics Submarket , By Application Forecast 2020-2030
Figure 5.18 Rest of World Metagenomics Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.19 Rest of World Metagenomics Market, by Forecast 2020-2030
Figure 5.20 Rest of World Metagenomics Submarket, By Technology Forecast 2020-2030
Figure 5.21 Rest of World Metagenomics Submarket , By Product Forecast 2020-2030
Figure 5.21 Rest of World Metagenomics Submarket , By Application Forecast 2020-2030
Figure 6.1 3M Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.2 Swift Biosciences, Inc Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.3 Bio-Rad Laboratories Total Company Sales 2013-2019 (US$ Bn, AGR %)
Figure 6.6 Merck KGaA Company Sales 2013-2019 (US$ bn, AGR %)
Figure 6.7 Merck KGaA Revenue % Share, by Application Segment, 2019
Figure 6.8 Merck KGaA Revenue % Share, by Geographical Trade, 2019
Figure 6.9 Merck KGaA Revenue % Share, by Business Segment, 2019
Figure 6.10 Promega Corporation Revenue % Share, by Geographic Segment, 2019
Figure 6.11 Luminex Corporation Company Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.12 BGI Group Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.13 BGI Group Revenue % Share, by Regional Segment, 2019
Figure 6.14 DNAstar, Inc. Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.15 DNAstar, Inc. Revenue % Share, by Regional Segment, 2019
Figure 6.16 DNAstar, Inc. Revenue % Share, by Business Segment, 2019
Figure 6.17 Eurofins Scientific Total Company Sales 2013-2019 (US$ bn, AGR %)
Figure 6.18 GENEWIZ Total Company Revenue 2013-2019 (US$ bn, AGR %)
Figure 6.19 GENEWIZ Company Sales 2014-2019 (US$ bn, AGR %)
Figure 6.20 GENEWIZ Revenue % Share, by Business Segment, 2019
List of Tables
Table 1.0 Research Scope
Table 4.1 Global Metagenomics Market Forecast 2020-2030 ($Bn, AGR %, CAGR %)
Table 4.2 Global Metagenomics Submarket, By Technology Forecast 2020-2030 ($billion, AGR %)
Table 4.3 Global Metagenomics Submarket, By Application Forecast 2020-2030 ($billion, AGR %)
Table 5.1 Global Metagenomics Market, by Country/Region Forecast 2020-2030 ($billion, AGR %)
Table 5.3 Europe Metagenomics Market Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.4 Europe Metagenomics Submarket, By Technology Forecast 2020-2030 ($billion, AGR %)
Table 5.5 Europe Metagenomics Submarket, By Product Forecast 2020-2030 ($billion, AGR %)
Table 5.6 North America Metagenomics Market Submarket, By Application Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.7 North America Metagenomics Submarket, By Technology Forecast 2020-2030 ($billion, AGR %)
Table 5.8 North America Metagenomics Submarket, By Product Forecast 2020-2030 ($billion, AGR %)
Table 5.9 Asia-Pacific Metagenomics Market Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.10 Asia-Pacific Metagenomics Submarket, By Technology Forecast 2020-2030 ($billion, AGR %)
Table 5.11 Asia-Pacific Metagenomics Submarket, By Product Forecast 2020-2030 ($billion, AGR %)
Table 5.12 Rest of World Metagenomics Market Submarket, By Application Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.13 Rest of World Metagenomics Submarket, By Technology Forecast 2020-2030 ($billion, AGR %)
Table 5.14 Rest of World Metagenomics Submarket, By Product Forecast 2020-2030 ($billion, AGR %)
Table 6.1 3M Profile 2019 (Market Entry, Public/Private, Headquarters, Geography, Key Market, Listed on, Products/Services
Table 6.2 3M Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.3 3M Products and Services (Product/Service, Segment)
Table 6.4 3M Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.5 3M Total Company Recent Development 2015-2019
Table 6.6 Swift Biosciences, Inc Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.7 Swift Biosciences, Inc Products and Services (Product/Service, Segment)
Table 6.8 Swift Biosciences, Inc Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.9 Swift Biosciences, Inc Total Company Recent Development 2015-2019
Table 6.10 Bio-Rad Laboratories Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.11 Bio-Rad Laboratories Products and Services (Product/Service, Segment)
Table 6.12 Bio-Rad Laboratories Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.13 Bio-Rad Laboratories Total Company Recent Development 2015-2019
Table 6.14 Merck KGaA Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.15 Merck KGaA Products and Services (Product/Service, Segment)
Table 6.16 Merck KGaA Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.17 Merck KGaA Total Company Recent Development 2015-2019
Table 6.18 Promega Corporation Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.19 Promega Corporation Products and Services (Product/Service, Segment)
Table 6.20 Promega Corporation Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.21 Promega Corporation Total Company Recent Development 2015-2019
Table 6.22 Luminex Corporation Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.23 Luminex Corporation Products and Services (Product/Service, Segment)
Table 6.24 Luminex Corporation Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.25 Luminex Corporation Total Company Recent Development 2015-2019
Table 6.26 BGI Group Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.27 BGI Group Products and Services (Product/Service, Segment)
Table 6.28 BGI Group Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.29 BGI Group Total Company Recent Development 2015-2019
Table 6.30 DNAstar, Inc. Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.31 DNAstar, Inc. Products and Services (Product/Service, Segment)
Table 6.32 DNAstar, Inc. Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.33 DNAstar, Inc. Total Company Recent Development 2015-2019
Table 6.34 Eurofins Scientific Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.35 Eurofins Scientific Products and Services (Product/Service, Segment)
Table 6.36 Eurofins Scientific Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.37 Eurofins Scientific Total Company Recent Development 2015-2019
Table 6.38 GENEWIZ Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.39 GENEWIZ Products and Services (Product/Service, Segment)
Table 6.40 GENEWIZ Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.41 GENEWIZ Total Company Recent Development 2015-2019
Top Companies
BGI Group
Bio-Rad Laboratories
DNAstar, Inc.
Eurofins Scientific
GENEWIZ
Illumina, Inc.
Luminex Corporation
Merck KGaA
PerkinElmer, Inc.,
Promega Corporation
Swift Biosciences, Inc
Other Companies
Agilent Technologies
AutoGenomics
Biocartis Group NV
ChunLab, Inc.
Danaher
ELITechGroup
Enterome SA,
F. Hoffmann-La Roche Ltd.,
Integragen SA
Macrogen, Inc.
Microsynth AG
Novogene Co., Ltd
NuGEN Technologies, Inc. (A Wholly Owned Subsidiary of Tecan Trading AG)
Oxford Gene Technology, Inc.
Oxford Nanopore Technologies, Ltd.
Pacific Biosciences of California, Inc.,
Perkinelmer, Inc.
Qiagen N.V.,
TAKARA BIO INC.
Thermo Fisher Scientific, Inc
uBiome, Inc.
Zymo Research Corporation